2018 First Half results press release

Download our press release published on 26 July to find out the financial results for the first half 2018.


No votes yet
 
Related
ROVI Share Buyback Program
TO THE SPANISH NATIONAL SECURITIES MARKET COMMISSION (COMISIÓN NACIONAL DEL MERCADO DE VALORES)   Madrid, 3 November 2021...
4 min
03/11/2021
The FDA delays its decision on Risperidone ISM®
The FDA delays its decision on Risperidone ISM® Madrid – 21 October, 2021 – Laboratorios Farmacéuticos Rovi, S.A. (“ROVI” or the “...
2 min
21/10/2021
ROVI informa del comunicado conjunto de Moderna y Takeda en relación con la investigación sobre los lotes bloqueados de la vacuna
Following the public relevant information published on 26 and on 29 of August 2021 with registered numbers 11377 and 11399 respectively,...
4 min
01/09/2021